Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
- PMID: 33083642
- PMCID: PMC7557128
- DOI: 10.1016/j.adro.2020.06.001
Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
Abstract
The backbone of treatment for patients with advanced-stage Hodgkin lymphoma is systemic therapy. The use of radiation therapy as a component of combined-modality treatment in this setting is controversial. In this review, we describe the data in support of and against the use of radiation therapy for stage III and IV Hodgkin lymphoma. Specifically, we review the data for the use of radiation therapy in the consolidation and partial-response settings, including for patients with initial bulky disease. We also discuss the use of radiation therapy in the era of more modern systemic therapies, including checkpoint inhibitors and brentuximab vedotin.
© 2020 The Authors.
Figures
References
-
- Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
-
- Hasenclever D., Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on advanced Hodgkin's disease. N Engl J Med. 1998;339:1506–1514. - PubMed
-
- Eichenauer D.A., Aleman B.M.P., Andre M. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv19–iv29. - PubMed
-
- Aleman B.M., Raemaekers J.M., Tirelli U. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med. 2003;348:2396–2406. - PubMed
-
- Johnson P.W., Sydes M.R., Hancock B.W. Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: Survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519) J Clin Oncol. 2010;28:3352–3359. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
